Johnson & Johnson buys Synthes for $21.3bn
Johnson & Johnson has agreed to buy Synthes, the Swiss medical device maker, for $21.3bn in cash and stock.
Johnson & Johnson is in talks to buy Swiss medical device maker Synthes for $20 billion, according to a report on the Wall Street Journal website, citing people familiar with the matter.